Enrich Biosystems
Enrich Biosystems is a biotech company based in Branford, CT, developing a novel high-throughput, microfluidics-free cell discovery platform called TROVO. The TROVO system enables researchers to 3D print thousands of microwells on standard microplates to culture, observe, and analyze thousands of cell micro-cultures simultaneously using fluorescent and bright field microscopy. It incorporates AI-powered tools for cell behavior analysis and allows for rapid selection and retrieval of cells based on function without microfluidics, reducing clogging and preserving cell viability. The platform is designed to accelerate cell therapy discovery, including T-cell, NK cell, and stem cell therapies, and supports applications such as tumor-killing T-cell identification, antibody discovery, and cell line development. Enrich Biosystems collaborates with research institutions and cell therapy developers, and its TROVO platform has gained traction in the US and Europe. The company has received NIH and NCI grants and industry recognition, including the BioTech Breakthrough "Cell Sorting Product of the Year" award. Its business model is primarily SaaS and product sales through its TROVO instrument and related application kits.
Enrich Biosystems
Enrich Biosystems is a biotech company based in Branford, CT, developing a novel high-throughput, microfluidics-free cell discovery platform called TROVO. The TROVO system enables researchers to 3D print thousands of microwells on standard microplates to culture, observe, and analyze thousands of cell micro-cultures simultaneously using fluorescent and bright field microscopy. It incorporates AI-powered tools for cell behavior analysis and allows for rapid selection and retrieval of cells based on function without microfluidics, reducing clogging and preserving cell viability. The platform is designed to accelerate cell therapy discovery, including T-cell, NK cell, and stem cell therapies, and supports applications such as tumor-killing T-cell identification, antibody discovery, and cell line development. Enrich Biosystems collaborates with research institutions and cell therapy developers, and its TROVO platform has gained traction in the US and Europe. The company has received NIH and NCI grants and industry recognition, including the BioTech Breakthrough "Cell Sorting Product of the Year" award. Its business model is primarily SaaS and product sales through its TROVO instrument and related application kits.